The aim of the current investigation is to evaluate the transdermal potential of novel vesicular carrier, ethosomes, bearing aceclofenac, Non-steroidal antiinflammatory drugs (NSAIDs) agents having limited transdermal permeation. Aceclofenac loaded ethosomal carriers were prepared, optimized and characterized for vesicular shape and surface morphology,(SEM) scanning electronic microscopy, vesic...

INTRODUCTION: The age-old theory that imparted the status of “dead, impermeable barrier devoid of biological activity” to skin had already been challenged by the development of pioneering transdermal product, but a less than impressive commercial growth in this sector had raised some doubts about the feasibility of this route as an efficient device of drug delivery. The journey of transdermal r...

Transdermal drug delivery systems have made significant contributions to the medical community, but have yet to completely substitute oral or parenteral delivery. Recently, various strategies have been used to augment the transdermal delivery of therapeutics. Primarily, they include iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, microneedles, and vesicular systems....

Transdermal route offers inherent advantages over other conventional routes for the delivery of drugs with systemic activity. Transdermal drug delivery provides a continuous mode of administration at rates approaching zero-order similar to that provided by an intravenous infusion.The greatest obstacle is the stratum corneum, the outermost layer of the skin, which is considered to form a primary...

Although transdermal drug delivery has many potential advantages, the permeability of skin to macromolecules is extremely low. However, the application of short, high-voltage pulses to electroporate skin has recently been shown to make it reversibly permeable. A number of studies have demonstrated that electroporation-mediated transdermal delivery of peptides, polysaccharides, oligonucleotides ...